StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

Research analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a report issued on Friday. The brokerage set a “sell” rating on the medical technology company’s stock.

BIOLASE Price Performance

Shares of BIOL stock opened at $0.01 on Friday. The business has a 50-day moving average of $0.01 and a 200 day moving average of $0.01. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94. The stock has a market capitalization of $416,919.36, a PE ratio of 0.00 and a beta of 0.67.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.